Skip to main content

Ashland Inc. (ASH)

Chemicals Basic Materials
Stock AI

Financial Metrics

Price to Earnings67.09x
Revenue Growth (1Y)-1.39%
Debt to Equity0.74x

Strengths

Stock Chart

Valuation

Ashland Inc. is overvalued

News

All
Press Releases
News
Filings
Ashland board authorizes quarterly dividend
August 07, 2026Ashland board authorizes quarterly dividend
10-Q Quarterly Report for 2026 Q3
July 29, 202610-Q Quarterly Report for 2026 Q3
Ashland reports third quarter 2026 results and reaffirms full-year sales & Adjusted EBITDA outlook
July 28, 2026Ashland reports third quarter 2026 results and reaffirms full-year sales & Adjusted EBITDA outlook
Ashland announces appointment of two new directors as part of Cooperation Agreement with stockholder Ancora
July 28, 2026Ashland announces appointment of two new directors as part of Cooperation Agreement with stockholder Ancora
Ashland sets date for third-quarter fiscal 2026 earnings release and conference call webcast
July 14, 2026Ashland sets date for third-quarter fiscal 2026 earnings release and conference call webcast
Ashland responds to investor presentation by Ancora Alternatives LLC
June 10, 2026Ashland responds to investor presentation by Ancora Alternatives LLC
Ashland Board appoints Bertrand Loy as new director
May 18, 2026Ashland Board appoints Bertrand Loy as new director
Ashland board authorizes quarterly dividend
May 05, 2026Ashland board authorizes quarterly dividend
10-Q Quarterly Report for 2026 Q2
April 29, 202610-Q Quarterly Report for 2026 Q2
Ashland reports second quarter fiscal 2026 results and updates full-year outlook
April 28, 2026Ashland reports second quarter fiscal 2026 results and updates full-year outlook
Ashland sets date for second-quarter fiscal 2026 earnings release and conference call webcast
April 15, 2026Ashland sets date for second-quarter fiscal 2026 earnings release and conference call webcast
Ashland implements pricing actions across product portfolio in response to market volatility
March 23, 2026Ashland implements pricing actions across product portfolio in response to market volatility
Ashland CFO to discuss current market environment at the Gabelli Funds’ 17th Annual Specialty Chemicals Symposium
March 17, 2026Ashland CFO to discuss current market environment at the Gabelli Funds’ 17th Annual Specialty Chemicals Symposium
Ashland agrimer™ eco-coat polymer seed coating from the Transformed Vegetable Oils (TVO) platform receives approval for all food and non-food uses in pesticide formulations including for sale in the U.S.
February 09, 2026Ashland agrimer™ eco-coat polymer seed coating from the Transformed Vegetable Oils (TVO) platform receives approval for all food and non-food uses in pesticide formulations including for sale in the U.S.
10-Q Quarterly Report for 2026 Q1
February 03, 202610-Q Quarterly Report for 2026 Q1
Ashland reports first quarter fiscal 2026 results and narrows full-year outlook
February 02, 2026Ashland reports first quarter fiscal 2026 results and narrows full-year outlook
Ashland sets date for first-quarter fiscal 2026 earnings release and conference call webcast
January 20, 2026Ashland sets date for first-quarter fiscal 2026 earnings release and conference call webcast
Ashland board authorizes quarterly dividend
January 19, 2026Ashland board authorizes quarterly dividend
Top 2 Materials Stocks That May Fall Off A Cliff This Quarter
December 05, 2025Top 2 Materials Stocks That May Fall Off A Cliff This Quarter
Silver Soars Past $58, Bitcoin-Strategy Bloodbath Deepens: What's Moving Markets Monday?
December 01, 2025Silver Soars Past $58, Bitcoin-Strategy Bloodbath Deepens: What's Moving Markets Monday?
10-K Annual Report for 2025 FY
November 20, 202510-K Annual Report for 2025 FY
Ashland board authorizes quarterly dividend
November 19, 2025Ashland board authorizes quarterly dividend
Ashland reports fourth quarter fiscal 2025 results and issues outlook for full-year 2026
November 04, 2025Ashland reports fourth quarter fiscal 2025 results and issues outlook for full-year 2026
Ashland changes start time for fourth-quarter fiscal 2025 earnings conference call webcast
October 30, 2025Ashland changes start time for fourth-quarter fiscal 2025 earnings conference call webcast
Ashland sets date for fourth-quarter fiscal 2025 earnings release and conference call webcast
October 23, 2025Ashland sets date for fourth-quarter fiscal 2025 earnings release and conference call webcast
Ashland announces Sandy Klugman, director, investor relations
October 14, 2025Ashland announces Sandy Klugman, director, investor relations
Ashland production unit at Calvert City is offline, equipment requires replacement with no impact expected to customer orders
September 30, 2025Ashland production unit at Calvert City is offline, equipment requires replacement with no impact expected to customer orders
Ashland board authorizes quarterly dividend
August 08, 2025Ashland board authorizes quarterly dividend
10-Q Quarterly Report for 2025 Q3
July 30, 202510-Q Quarterly Report for 2025 Q3
Ashland reports third quarter fiscal 2025 results and narrows full-year outlook range
July 29, 2025Ashland reports third quarter fiscal 2025 results and narrows full-year outlook range
Whitaker named senior vice president and chief financial officer, Ashland
July 21, 2025Whitaker named senior vice president and chief financial officer, Ashland
Ashland sets date for third-quarter fiscal 2025 earnings release and conference call webcast
July 16, 2025Ashland sets date for third-quarter fiscal 2025 earnings release and conference call webcast
Operations leadership changes announced at Ashland
July 14, 2025Operations leadership changes announced at Ashland
Ashland advances strategic $60MM network optimization
July 08, 2025Ashland advances strategic $60MM network optimization
Ashland hosts Innovation Day for analysts and investors
May 28, 2025Ashland hosts Innovation Day for analysts and investors
Ashland announces executive leadership changes
May 05, 2025Ashland announces executive leadership changes
10-Q Quarterly Report for 2025 Q2
May 01, 202510-Q Quarterly Report for 2025 Q2
Ashland reports second quarter fiscal 2025 results and revises full-year outlook
April 30, 2025Ashland reports second quarter fiscal 2025 results and revises full-year outlook
This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
March 26, 2025This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
10-Q Quarterly Report for 2025 Q1
January 29, 202510-Q Quarterly Report for 2025 Q1
10-K Annual Report for 2024 FY
November 18, 202410-K Annual Report for 2024 FY
10-Q Quarterly Report for 2024 Q3
August 07, 202410-Q Quarterly Report for 2024 Q3
10-Q Quarterly Report for 2024 Q2
May 01, 202410-Q Quarterly Report for 2024 Q2
10-Q Quarterly Report for 2024 Q1
January 31, 202410-Q Quarterly Report for 2024 Q1
10-K Annual Report for 2023 FY
November 17, 202310-K Annual Report for 2023 FY
10-Q Quarterly Report for 2023 Q3
July 27, 202310-Q Quarterly Report for 2023 Q3
10-Q Quarterly Report for 2023 Q2
May 03, 202310-Q Quarterly Report for 2023 Q2
10-Q Quarterly Report for 2023 Q1
February 01, 202310-Q Quarterly Report for 2023 Q1
10-K Annual Report for 2022 FY
November 21, 202210-K Annual Report for 2022 FY
10-Q Quarterly Report for 2022 Q3
July 28, 202210-Q Quarterly Report for 2022 Q3
10-Q Quarterly Report for 2022 Q2
April 28, 202210-Q Quarterly Report for 2022 Q2
10-Q Quarterly Report for 2022 Q1
February 03, 202210-Q Quarterly Report for 2022 Q1
10-K Annual Report for 2021 FY
November 22, 202110-K Annual Report for 2021 FY

A. Company Overview

Ashland Inc. is a multinational specialty additives and materials corporation incorporated in Delaware, United States. The company is headquartered at 8145 Blazer Drive, Wilmington, Delaware. The designation "Ashland" encompasses Ashland Inc., its predecessors, and its consolidated subsidiaries unless otherwise specified. Operating with an acute awareness of sustainability, Ashland serves diverse consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company employs approximately 3,800 individuals globally and provides services to customers in over 100 countries.

Ashland's operational structure is categorized into reportable segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Unallocated and Other segment comprises corporate governance activities and certain legacy matters not falling into the primary segments.

B. Business Segments

Life Sciences

The Life Sciences segment is notable for supplying pharmaceutical solutions, nutrition enhancers, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. Key offerings include:

  • Pharmaceutical Solutions: These encompass controlled-release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders.
  • Nutrition Solutions: This category includes thickeners, stabilizers, emulsifiers, and various additives designed to improve mouthfeel and control moisture migration in food products.
  • Nutraceuticals: Products aimed at weight management, joint comfort, stomach health, sports nutrition, and overall wellness. This segment also offers custom formulation, toll processing, and particle engineering solutions.

Life Sciences caters to a wide range of industries including pharmaceuticals and nutraceutical manufacturers, food and beverage producers, hospitals, and industrial manufacturers, with a substantial operational footprint across the Americas, Europe, and Asia Pacific.

Personal Care

The Personal Care segment delivers comprehensive product offerings impacting oral care (toothpaste and mouthwash ingredients), hair care, and skin care. Solutions include:

  • Hair Care: Advanced styling polymers, conditioning agents, emulsifiers, and preservatives that enhance the quality of grooming products.
  • Skin Care and Cosmetics: Ingredients focused on natural and sustainable solutions include biofunctional actives and specialty polymers.
  • Household Solutions: A diverse array of ingredients developed for cleaning applications that include surface wetting agents and rheology modifiers.

The Personal Care segment has manufacturing facilities in several countries and caters to both multinational branded companies and smaller, niche firms.

Specialty Additives

Specialty Additives is focused on rheology and performance-enhancing products used in various industrial applications. This segment offers solutions for:

  • Architectural Coatings: Products such as hydroxyethylcellulose (HEC) for thickening and application properties in paints.
  • Construction Materials: Cellulose ethers and other additives that enhance properties like workability and adhesion in construction mixes.
  • Industrial Applications: Performance additives including binders and surfactants that serve more than 30 industries.

This segment establishes its market presence through an emphasis on innovation and a vast portfolio of polymer-based solutions that cater to an array of customer needs.

Intermediates

The Intermediates segment is centered on the production of 1,4-butanediol (BDO) and related derivatives, including n-methylpyrrolidone. These products serve as critical chemical intermediates in engineering polymers and polyurethane production, as well as in specialty solvents applicable to various sectors, such as electronics and pharmaceuticals.

The Intermediates segment is also strategically integrated with the Life Sciences, Personal Care, and Specialty Additives segments as it supplies core materials essential for their production processes.

C. Manufacturing and Operational Facilities

Ashland operates numerous manufacturing and laboratory facilities across the globe. Life Sciences operates 19 facilities in nine countries, Personal Care has 15 manufacturing and lab facilities, and Specialty Additives has 11 such facilities. Infrastructure spans significant locations in the United States, Europe, and Asia, facilitating robust distribution networks essential for local and international markets.

D. Competition

The specialty additives and ingredients marketplace is characterized by intense competition due to its fragmented nature. Ashland competes on various criteria including product quality, performance, pricing, service, and innovation. Notably, larger competitors may possess more substantial financial resources, which impacts market share dynamics. Ashland continues to hone its competitive edge by refining its corporate brand while focusing on customer collaboration in product development.

E. Intellectual Property

Intellectual property serves as a cornerstone for Ashland's business advantage. A diverse portfolio of patents, trade secrets, formulas, and proprietary technologies safeguards its unique offerings. Trademarks further aid in distinguishing Ashland’s products in the marketplace.

F. Research and Development

Research and development at Ashland plays a crucial role in understanding market needs and transforming them into actionable technology platforms. The focus includes developing new chemistries, innovative technologies, and customer-specific solutions across various technology centers globally to drive competitiveness.

Stock Infos

SectorBasic Materials
IndustryChemicals
CEOGuillermo Novo

Dividends

Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.